Changing from NAFLD through MAFLD to MASLD: Similar prevalence and risk factors in a large Brazilian cohort

We read with great interest the multi-society statement on new fatty liver disease nomenclature published by the NAFLD Nomenclature Consensus Group.1 The term non-alcoholic fatty liver disease (NAFLD), formerly metabolic dysfunction-associated fatty liver disease (MAFLD),2 will now be metabolic dysfunction-associated steatotic liver disease (MASLD). Additionally, metabolic dysfunction-associated steatohepatitis (MASH) will replace the term non-alcoholic steatohepatitis (NASH). We aimed to compare the burden of the fatty liver disease in participants from the ELSA-Brasil study using the different nomenclature/criteria.